Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $60 | $123 | $83 | $43 |
| - Cash | $13 | $23 | $19 | $30 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $47 | $99 | $64 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$30 | -$39 | -$24 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$39 | -$24 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.9 | -1.65 | -1.45 | -0.58 |
| % Growth | 45.5% | -13.8% | -150% | – |
| Operating Cash Flow | -$34 | -$28 | -$19 | -$11 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$34 | -$28 | -$19 | -$11 |